Norton Medical and Scientific Research & Biotechnology - FDA approves kidney cancer drug from Pfizer
By admin, 3 months and 20 days ago
The medicine made by Pfizer against advanced kidney cancer was recently approved by Norton Medical and Scientific Research & Biotechnology regulators for commercial use despite a warning of possible side effects. On Friday, the Food and Drug Administration (FDA) stated that the drug (with the generic name of axitinib) is effective in curing patients...
Delicious
Digg
Furl
Magnolia
Reddit
Slashdot
Stumbleupon
Technorati Favorites
3 comments
No trackbacks